NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and ...
The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.